Laurus Labs Limited has scheduled an investor meeting in Hyderabad on June 12, 2026, as part of the Goldman Sachs India CRO/CDMO Tour. The company will engage with analysts and institutional investors through one-on-one and group interactions. This meeting provides stakeholders an opportunity to discuss the company's operations and strategy without the disclosure of unpublished price sensitive information.

The intimation was made pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company noted that the date of the meeting is subject to change due to exigencies on the part of investors or the company.

Meeting Details

G. Venkateswar Reddy, Company Secretary & Compliance Officer, signed the disclosure on behalf of Laurus Labs Limited.

Laurus Labs Limited’s promoter group has confirmed that no new encumbrances were created on its shares during the financial year 2025-26. This declaration ensures that the shares held by the promoters and persons acting in concert remain free from charges other than those previously disclosed to the exchanges.

The disclosure was submitted to the stock exchanges on April 07, 2026, by Venkata Ravi Kumar Vantaram, Whole-time Director & CFO cum Promoter. The filing was made in compliance with Regulation 31(4) read with Regulation 31(5) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The regulation mandates promoters to disclose any encumbrance of shares to ensure transparency in shareholding patterns.

The declaration covers the entire promoter group, comprising 17 members categorized as either promoters or persons acting in concert. The list includes key individuals such as Satyanarayana Chava and Chava Naga Rani, as well as corporate entities like M/s. NSN Holdings and M/s. Leven Holdings.

The following table details the members of the promoter group included in the declaration:

The confirmation of no additional encumbrances provides clarity to investors regarding the financial standing of the company’s primary shareholders.